IBDEI0NI ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11570,1,2,0)
 ;;=2^CHOLANGIOCARCINOMA
 ;;^UTILITY(U,$J,358.3,11570,2)
 ;;=^267102
 ;;^UTILITY(U,$J,358.3,11571,0)
 ;;=286.9^^79^761^14
 ;;^UTILITY(U,$J,358.3,11571,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11571,1,1,0)
 ;;=1^286.9
 ;;^UTILITY(U,$J,358.3,11571,1,2,0)
 ;;=2^COAGULATION DEFECTS
 ;;^UTILITY(U,$J,358.3,11571,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,11572,0)
 ;;=156.9^^79^761^17
 ;;^UTILITY(U,$J,358.3,11572,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11572,1,1,0)
 ;;=1^156.9
 ;;^UTILITY(U,$J,358.3,11572,1,2,0)
 ;;=2^GALLBLADDER CANCER
 ;;^UTILITY(U,$J,358.3,11572,2)
 ;;=^267102
 ;;^UTILITY(U,$J,358.3,11573,0)
 ;;=459.0^^79^761^19
 ;;^UTILITY(U,$J,358.3,11573,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11573,1,1,0)
 ;;=1^459.0
 ;;^UTILITY(U,$J,358.3,11573,1,2,0)
 ;;=2^HEMORRHAGE NOS
 ;;^UTILITY(U,$J,358.3,11573,2)
 ;;=^55877
 ;;^UTILITY(U,$J,358.3,11574,0)
 ;;=176.9^^79^761^20
 ;;^UTILITY(U,$J,358.3,11574,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11574,1,1,0)
 ;;=1^176.9
 ;;^UTILITY(U,$J,358.3,11574,1,2,0)
 ;;=2^KAPOSI'S SARCOMA, NOS
 ;;^UTILITY(U,$J,358.3,11574,2)
 ;;=^107993
 ;;^UTILITY(U,$J,358.3,11575,0)
 ;;=161.9^^79^761^21
 ;;^UTILITY(U,$J,358.3,11575,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11575,1,1,0)
 ;;=1^161.9
 ;;^UTILITY(U,$J,358.3,11575,1,2,0)
 ;;=2^LARYNGEAL CANCER
 ;;^UTILITY(U,$J,358.3,11575,2)
 ;;=^267128
 ;;^UTILITY(U,$J,358.3,11576,0)
 ;;=208.90^^79^761^22
 ;;^UTILITY(U,$J,358.3,11576,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11576,1,1,0)
 ;;=1^208.90
 ;;^UTILITY(U,$J,358.3,11576,1,2,0)
 ;;=2^LEUKEMIA,UNSP CELL TYPE
 ;;^UTILITY(U,$J,358.3,11576,2)
 ;;=^336874
 ;;^UTILITY(U,$J,358.3,11577,0)
 ;;=140.9^^79^761^23
 ;;^UTILITY(U,$J,358.3,11577,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11577,1,1,0)
 ;;=1^140.9
 ;;^UTILITY(U,$J,358.3,11577,1,2,0)
 ;;=2^LIP CANCER
 ;;^UTILITY(U,$J,358.3,11577,2)
 ;;=^266994
 ;;^UTILITY(U,$J,358.3,11578,0)
 ;;=155.0^^79^761^24
 ;;^UTILITY(U,$J,358.3,11578,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11578,1,1,0)
 ;;=1^155.0
 ;;^UTILITY(U,$J,358.3,11578,1,2,0)
 ;;=2^LIVER CANCER
 ;;^UTILITY(U,$J,358.3,11578,2)
 ;;=^73526
 ;;^UTILITY(U,$J,358.3,11579,0)
 ;;=200.60^^79^761^26
 ;;^UTILITY(U,$J,358.3,11579,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11579,1,1,0)
 ;;=1^200.60
 ;;^UTILITY(U,$J,358.3,11579,1,2,0)
 ;;=2^LYMPHOMA,ANAPLASTIC LARGE CELL
 ;;^UTILITY(U,$J,358.3,11579,2)
 ;;=^335299
 ;;^UTILITY(U,$J,358.3,11580,0)
 ;;=200.20^^79^761^27
 ;;^UTILITY(U,$J,358.3,11580,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11580,1,1,0)
 ;;=1^200.20
 ;;^UTILITY(U,$J,358.3,11580,1,2,0)
 ;;=2^LYMPHOMA,BURKITT'S
 ;;^UTILITY(U,$J,358.3,11580,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,11581,0)
 ;;=201.90^^79^761^28
 ;;^UTILITY(U,$J,358.3,11581,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11581,1,1,0)
 ;;=1^201.90
 ;;^UTILITY(U,$J,358.3,11581,1,2,0)
 ;;=2^LYMPHOMA,HODGKIN'S
 ;;^UTILITY(U,$J,358.3,11581,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,11582,0)
 ;;=200.70^^79^761^29
 ;;^UTILITY(U,$J,358.3,11582,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11582,1,1,0)
 ;;=1^200.70
 ;;^UTILITY(U,$J,358.3,11582,1,2,0)
 ;;=2^LYMPHOMA,LARGE CELL
 ;;^UTILITY(U,$J,358.3,11582,2)
 ;;=^335300
 ;;^UTILITY(U,$J,358.3,11583,0)
 ;;=200.40^^79^761^30
 ;;^UTILITY(U,$J,358.3,11583,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11583,1,1,0)
 ;;=1^200.40
 ;;^UTILITY(U,$J,358.3,11583,1,2,0)
 ;;=2^LYMPHOMA,MANTLE CELL
 ;;^UTILITY(U,$J,358.3,11583,2)
 ;;=^335297
 ;;^UTILITY(U,$J,358.3,11584,0)
 ;;=200.30^^79^761^31
 ;;^UTILITY(U,$J,358.3,11584,1,0)
 ;;=^358.31IA^2^2
